ESBES Virtual - Platform technologies – enabler for rapid manufacturing of a large vaccine supply to combat COVID-19

September 16, 2021 - September 16, 2021, 18:30 - 20:00 hrs (CEST) - Virtual



Organized by:    ACS-BIOT/ESBES COVID19 working group

Chairs:              William J. Kelly, Villanova University
                        Alois Jungbauer, BOKU University


Leveraging mRNA Platform Technologies to Enable Pandemic Supply of COVID-19 Vx.

Khurram Sunasara, PhD
Group leader in Pfizer Inc.’s Bioprocess R&D group, Saint Louis, MO, USA
Co-lead of Pharmaceutical Science’s COVID-19 mRNA vaccine drug substance team responsible for process development, scale-up and process characterization


Applying the AdVacPlatform to Development of a COVID-19 Vaccine

Joanke Graveland-Bikker PhD
Senior Technical Integrator at Janssen Vaccines and Prevention B.V., Leiden, The Netherlands

Pepijn Burgers PhD
Associate Scientific Director at Janssen Vaccines and Prevention B.V., Leiden, Netherlands



© DECHEMA e.V. 1995-2022 alle Rechte vorbehalten

[close window]